CD77 levels over enzyme replacement treatment in Fabry Disease Family (V269M)

INTRODUCTION: Fabry disease (FD) is a disorder caused by mutations in the gene encoding for lysosomal enzyme α-galactosidase A (α-GAL). Reduced α-GAL activity leads to progressive accumulation of globotriaosylceramide (Gb3), also known as CD77. The recent report of increased expression of CD77 in bl...

Descripción completa

Detalles Bibliográficos
Autores principales: Pereira, Ester Miranda, da Silva, Adalberto Socorro, da Silva, Raimundo Nonato, Monte, José Tiburcio, do Nascimento, Fernando F., Sousa, Jackeline L. M., Costa, Henrique César Saraiva de Arêa Leão, Sales, Herton Luiz Alves, Labilloy, Anatalia, do Monte, Semiramis Jamil Hadad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Nefrologia 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6534003/
https://www.ncbi.nlm.nih.gov/pubmed/29927462
http://dx.doi.org/10.1590/2175-8239-JBN-3910

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6534003/
https://www.ncbi.nlm.nih.gov/pubmed/29927462
http://dx.doi.org/10.1590/2175-8239-JBN-3910

Ejemplares similares